Raymond James Upgrades Blueprint Medicines to Strong Buy

Raymond James upgrades Blueprint Medicines (NASDAQ:BPMC) from Outperform to Strong Buy.

Benzinga · 11/06/2019 11:08

Raymond James upgrades Blueprint Medicines (NASDAQ:BPMC) from Outperform to Strong Buy.